News Image

PainReform Ltd. enters into a Strategic Investment Agreement to Expand its Non-Opiate Pain Management Pipeline into Opthamology with LayerBio

Provided By GlobeNewswire

Last update: Jul 10, 2025

TEL AVIV, Israel, July 10, 2025 (GLOBE NEWSWIRE) -- PainReform Ltd. (Nasdaq: PRFX), today announced, through its pharmaceutical division, the signing of a strategic investment agreement with LayerBio Inc., a privately held Boston biotechnology company developing proprietary, long-acting, non-opiate treatments for ophthalmic surgery.

Read more at globenewswire.com

PAINREFORM LTD

NASDAQ:PRFX (10/17/2025, 8:00:01 PM)

After market: 1.23 -0.01 (-0.81%)

1.24

-0.01 (-0.4%)



Find more stocks in the Stock Screener

Follow ChartMill for more